Chapter/Section Purchase

1 Study Coverage
1.1 Asthma Medication Product Introduction
1.2 Market by Type
1.2.1 Global Asthma Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.2.4 Asthma Medications During Pregnancy
1.3 Market by Application
1.3.1 Global Asthma Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Asthma Medication Sales Estimates and Forecasts 2017-2028
2.2 Global Asthma Medication Revenue Estimates and Forecasts 2017-2028
2.3 Global Asthma Medication Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Asthma Medication Sales by Region
2.4.1 Global Asthma Medication Sales by Region (2017-2022)
2.4.2 Global Sales Asthma Medication by Region (2023-2028)
2.5 Global Asthma Medication Revenue by Region
2.5.1 Global Asthma Medication Revenue by Region (2017-2022)
2.5.2 Global Asthma Medication Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Asthma Medication Sales by Manufacturers
3.1.1 Global Top Asthma Medication Manufacturers by Sales (2017-2022)
3.1.2 Global Asthma Medication Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma Medication in 2021
3.2 Global Asthma Medication Revenue by Manufacturers
3.2.1 Global Asthma Medication Revenue by Manufacturers (2017-2022)
3.2.2 Global Asthma Medication Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Asthma Medication Revenue in 2021
3.3 Global Asthma Medication Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Asthma Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Asthma Medication Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Asthma Medication Sales by Type
4.1.1 Global Asthma Medication Historical Sales by Type (2017-2022)
4.1.2 Global Asthma Medication Forecasted Sales by Type (2023-2028)
4.1.3 Global Asthma Medication Sales Market Share by Type (2017-2028)
4.2 Global Asthma Medication Revenue by Type
4.2.1 Global Asthma Medication Historical Revenue by Type (2017-2022)
4.2.2 Global Asthma Medication Forecasted Revenue by Type (2023-2028)
4.2.3 Global Asthma Medication Revenue Market Share by Type (2017-2028)
4.3 Global Asthma Medication Price by Type
4.3.1 Global Asthma Medication Price by Type (2017-2022)
4.3.2 Global Asthma Medication Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Asthma Medication Sales by Application
5.1.1 Global Asthma Medication Historical Sales by Application (2017-2022)
5.1.2 Global Asthma Medication Forecasted Sales by Application (2023-2028)
5.1.3 Global Asthma Medication Sales Market Share by Application (2017-2028)
5.2 Global Asthma Medication Revenue by Application
5.2.1 Global Asthma Medication Historical Revenue by Application (2017-2022)
5.2.2 Global Asthma Medication Forecasted Revenue by Application (2023-2028)
5.2.3 Global Asthma Medication Revenue Market Share by Application (2017-2028)
5.3 Global Asthma Medication Price by Application
5.3.1 Global Asthma Medication Price by Application (2017-2022)
5.3.2 Global Asthma Medication Price Forecast by Application (2023-2028)
6 North America
6.1 North America Asthma Medication Market Size by Type
6.1.1 North America Asthma Medication Sales by Type (2017-2028)
6.1.2 North America Asthma Medication Revenue by Type (2017-2028)
6.2 North America Asthma Medication Market Size by Application
6.2.1 North America Asthma Medication Sales by Application (2017-2028)
6.2.2 North America Asthma Medication Revenue by Application (2017-2028)
6.3 North America Asthma Medication Market Size by Country
6.3.1 North America Asthma Medication Sales by Country (2017-2028)
6.3.2 North America Asthma Medication Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Asthma Medication Market Size by Type
7.1.1 Europe Asthma Medication Sales by Type (2017-2028)
7.1.2 Europe Asthma Medication Revenue by Type (2017-2028)
7.2 Europe Asthma Medication Market Size by Application
7.2.1 Europe Asthma Medication Sales by Application (2017-2028)
7.2.2 Europe Asthma Medication Revenue by Application (2017-2028)
7.3 Europe Asthma Medication Market Size by Country
7.3.1 Europe Asthma Medication Sales by Country (2017-2028)
7.3.2 Europe Asthma Medication Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Asthma Medication Market Size by Type
8.1.1 Asia Pacific Asthma Medication Sales by Type (2017-2028)
8.1.2 Asia Pacific Asthma Medication Revenue by Type (2017-2028)
8.2 Asia Pacific Asthma Medication Market Size by Application
8.2.1 Asia Pacific Asthma Medication Sales by Application (2017-2028)
8.2.2 Asia Pacific Asthma Medication Revenue by Application (2017-2028)
8.3 Asia Pacific Asthma Medication Market Size by Region
8.3.1 Asia Pacific Asthma Medication Sales by Region (2017-2028)
8.3.2 Asia Pacific Asthma Medication Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Asthma Medication Market Size by Type
9.1.1 Latin America Asthma Medication Sales by Type (2017-2028)
9.1.2 Latin America Asthma Medication Revenue by Type (2017-2028)
9.2 Latin America Asthma Medication Market Size by Application
9.2.1 Latin America Asthma Medication Sales by Application (2017-2028)
9.2.2 Latin America Asthma Medication Revenue by Application (2017-2028)
9.3 Latin America Asthma Medication Market Size by Country
9.3.1 Latin America Asthma Medication Sales by Country (2017-2028)
9.3.2 Latin America Asthma Medication Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Asthma Medication Market Size by Type
10.1.1 Middle East and Africa Asthma Medication Sales by Type (2017-2028)
10.1.2 Middle East and Africa Asthma Medication Revenue by Type (2017-2028)
10.2 Middle East and Africa Asthma Medication Market Size by Application
10.2.1 Middle East and Africa Asthma Medication Sales by Application (2017-2028)
10.2.2 Middle East and Africa Asthma Medication Revenue by Application (2017-2028)
10.3 Middle East and Africa Asthma Medication Market Size by Country
10.3.1 Middle East and Africa Asthma Medication Sales by Country (2017-2028)
10.3.2 Middle East and Africa Asthma Medication Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dulera
11.1.1 Dulera Corporation Information
11.1.2 Dulera Overview
11.1.3 Dulera Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dulera Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dulera Recent Developments
11.2 QVAR
11.2.1 QVAR Corporation Information
11.2.2 QVAR Overview
11.2.3 QVAR Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 QVAR Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 QVAR Recent Developments
11.3 Glaxosmithkline plc
11.3.1 Glaxosmithkline plc Corporation Information
11.3.2 Glaxosmithkline plc Overview
11.3.3 Glaxosmithkline plc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Glaxosmithkline plc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Glaxosmithkline plc Recent Developments
11.4 MAP Pharmaceuticals?Inc
11.4.1 MAP Pharmaceuticals?Inc Corporation Information
11.4.2 MAP Pharmaceuticals?Inc Overview
11.4.3 MAP Pharmaceuticals?Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MAP Pharmaceuticals?Inc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MAP Pharmaceuticals?Inc Recent Developments
11.5 Merck & Co. Inc
11.5.1 Merck & Co. Inc Corporation Information
11.5.2 Merck & Co. Inc Overview
11.5.3 Merck & Co. Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck & Co. Inc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck & Co. Inc Recent Developments
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Corporation Information
11.6.2 AstraZeneca plc Overview
11.6.3 AstraZeneca plc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AstraZeneca plc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AstraZeneca plc Recent Developments
11.7 Roche Holdings Ltd
11.7.1 Roche Holdings Ltd Corporation Information
11.7.2 Roche Holdings Ltd Overview
11.7.3 Roche Holdings Ltd Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Roche Holdings Ltd Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Roche Holdings Ltd Recent Developments
11.8 Genentech Inc
11.8.1 Genentech Inc Corporation Information
11.8.2 Genentech Inc Overview
11.8.3 Genentech Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genentech Inc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech Inc Recent Developments
11.9 Sepracor, Inc
11.9.1 Sepracor, Inc Corporation Information
11.9.2 Sepracor, Inc Overview
11.9.3 Sepracor, Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sepracor, Inc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sepracor, Inc Recent Developments
11.10 Schering-Plough Corp
11.10.1 Schering-Plough Corp Corporation Information
11.10.2 Schering-Plough Corp Overview
11.10.3 Schering-Plough Corp Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Schering-Plough Corp Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Schering-Plough Corp Recent Developments
11.11 Sanofi-Aventis
11.11.1 Sanofi-Aventis Corporation Information
11.11.2 Sanofi-Aventis Overview
11.11.3 Sanofi-Aventis Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sanofi-Aventis Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi-Aventis Recent Developments
11.12 Theravance Inc
11.12.1 Theravance Inc Corporation Information
11.12.2 Theravance Inc Overview
11.12.3 Theravance Inc Asthma Medication Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Theravance Inc Asthma Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Theravance Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma Medication Industry Chain Analysis
12.2 Asthma Medication Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma Medication Production Mode & Process
12.4 Asthma Medication Sales and Marketing
12.4.1 Asthma Medication Sales Channels
12.4.2 Asthma Medication Distributors
12.5 Asthma Medication Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Asthma Medication Industry Trends
13.2 Asthma Medication Market Drivers
13.3 Asthma Medication Market Challenges
13.4 Asthma Medication Market Restraints
14 Key Findings in The Global Asthma Medication Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer